Clinical Trials in San Antonio

Showing 9481-9500 of 14,633 trials

Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors

NCT03454243

This is a first-in-human, open label, multicenter, dose escalation study of RXDX-106 in patients with locally advanced or metastatic solid tumors, who have no available therapy likely to convey clinical benefit. This study will examine the safety, tolerability, pharmacokinetics (PK), pharmacodynamics and preliminary efficacy of RXDX 106.

Advanced or Metastatic Solid Tumors

Hoffmann-La Roche1 participantsStarted Feb 2018

San Antonio, Texas, United States

TERMINATEDNA< 1 mile

Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour)

NCT02388880

The purpose of the study is to evaluate the physiological response to application of the Intrathoracic Pressure Regulator (ITPR) in patients with compromised cerebral circulation. The study will evaluate the physiological response to intrathoracic pressure regulation (IPR) therapy in hemodynamically stable patients with compromised cerebral circulation who are on ventilatory support.

Head InjuryIntracranial PathologyCompromised Cerebral Perfusion

Advanced Circulatory Systems3 participantsStarted Feb 2015

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

NCT01211873

The purpose of this study is to look at the safety (what are the side effects)and efficacy (how well does it work) of Dotarem® when used in taking images of the brain / spine. The results will be compared to the results of MRI taken without Dotarem.

Diagnostic Self EvaluationCentral Nervous System Diseases

Guerbet416 participantsStarted Sep 2010

Birmingham, Alabama, United States • Tucson, Arizona, United States • Tucson, Arizona, United States +49 more locations

Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors

Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour)

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

Find Trials by Condition in San Antonio

Safety, Pharmacokinetics, and Pharmacodynamics of SD-101 in Healthy Normal Males

24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis

Sorafenib for Hepatopulmonary Syndrome

Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome

Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

10003 PRO Current Products

A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children